Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.36
-2.36 (-5.94%)
At close: Mar 31, 2025, 4:00 PM
36.00
-1.36 (-3.64%)
After-hours: Mar 31, 2025, 6:40 PM EDT

Apogee Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Selling, General & Admin
49.0124.583.21
Research & Development
167.8768.4230.31
Operating Expenses
216.879333.52
Operating Income
-216.87-93-33.52
Interest & Investment Income
34.749.020.1
Other Non Operating Income (Expenses)
---9.98
Pretax Income
-182.13-83.99-43.4
Income Tax Expense
0.02--
Net Income
-182.15-83.99-43.4
Net Income to Common
-182.15-83.99-43.4
Shares Outstanding (Basic)
55252
Shares Outstanding (Diluted)
55252
Shares Change (YoY)
120.72%915.57%-
EPS (Basic)
-3.30-3.36-17.63
EPS (Diluted)
-3.30-3.36-17.63
Free Cash Flow
-172.33-74.93-17.92
Free Cash Flow Per Share
-3.12-3.00-7.28
EBITDA
-216.68--
D&A For EBITDA
0.19--
EBIT
-216.87-93-33.52
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q